Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (67)

Latest Posts

About This Stock More About This Stock
5 More Monster Stocks To Watch For The Week Of September 30
Article By: Michael J. Kramer
Sunday, September 29, 2019 1:42 PM EDT
Here are a few more stocks that should be on the watch list for the week of September 30: Apple, Netflix, Regeneron, Roku and Tesla.
In this article: REGN, AAPL, NFLX, TSLA, ROKU
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes
Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
Top Five Weekend Stock Stories - May 19, 2019
Article By: The Fly
Sunday, May 19, 2019 8:37 PM EDT
Catch up on the weekend's top five stories with this list compiled by The Fly...
In this article: BWA, DIS, JWN, MCD, SCHW, TSN, REGN, AMAT, GOOG, TTWO, GOOGL, TPR, LGF-A
Read
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Article By: Benzinga
Saturday, April 27, 2019 6:05 PM EDT
Biotech stocks staged a recovery this week after being in the red in the previous two weeks.
In this article: BTX, BOLD, REGN, BIIB, GWPH, ALDX, HRTX, IONS, ADAP, NBRV, BHVN, NVS, SNY, RHHBY, ABBV
Read
Biotech Stocks Hold After Brief Sell-Off Last Week…Updates
Article By: Rod Raynovich
Sunday, March 10, 2019 12:22 PM EDT
Biotech ETFs lost momentum last week but held near term support near the 20 Day moving average. Now that most companies have reported we should not expect fundamentals to create volatility.
In this article: BMY, MRK, RHHBY, IBB, REGN, CELG, GILD, VRTX, XBI, ABBV
Read

PARTNER HEADLINES

Latest Tweets for $REGN

No tweets yet!

$REGN

Regeneron Pharmaceuticals’ Dupixent Has Multi-Billion-Dollar Potential: Polen Capital
David J. Tanner 1/31/2018 3:55:05 AM

Note it has only been approved in Japan. And only for those whom existing treatments are ineffective. So that's a MUCH smaller market. How small I don't know. But not enough to make me bite. $REGN

1 to 1 of 1 comments